Article

Longitudinal trajectory of menopausal symptoms in premenopausal women throughout adjuvant chemotherapy: a two-stage analytical approach

2025-03-04

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose</bold> Breast cancer incidence in Asian women peaks in the mid-40s, when many remain premenopausal. The progression of chemotherapy-induced menopausal symptoms in this population remains underexplored. This study examined their temporal trajectory and clinical significance during adjuvant chemotherapy. <bold>Method</bold> This prospective study assessed breast cancer patie...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5ecdb2de-28b0-57c5-b7e2-1ef83ae1406c
DOI: 10.21203/rs.3.rs-6106285/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Longitudinal trajectory of menopausal symptoms in premenopausal women throughout adjuvant chemotherapy: a two-stage analytical approachDOI 10.21203/rs.3.rs-6106285/v1Read

Changes in the severity of chemotherapy-induced nausea and vomiting according to the menopausal stage of breast cancer patients during adjuvant chemotherapy: A prospective observational studySemantic proximity Read

Chemotherapy-Induced Nausea and Vomiting Breast Cancer Patients from a Chinese Multicenter Prospective Longitudinal Observational StudySemantic proximity Read

Survival of Breast Cancer Patients and Associated Factors at the Douala General HospitalSemantic proximity Read

Thinking beyond the tumor to better understand chronic symptoms in breast cancer survivors.Semantic proximity Read

Factors Causing Delayed Presentations of Breast Cancer among Female patients in Sulaimaniyah Governorate, IraqSemantic proximity Read

Genes Involved in the HPA Axis and the Symptom Cluster of Fatigue, Depressive Symptoms, and Anxiety in Women With Breast Cancer During 18 Months of Adjuvant Therapy.Semantic proximity Read

Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk.Semantic proximity Read

Clustering of >145,000 Symptom Logs Reveals Distinct Pre, Peri, and Post Menopausal PhenotypesSemantic proximity Read

Tamoxifen protects breast cancer patients from COVID-19: first evidence from real world dataSemantic proximity Read

Reclassifying Menopausal Breast Cancer and Assessing Non-Genetic Risk Factors in Ghanaian Women: Insights from a Cohort StudySemantic proximity Read

Hormonal Replacement Therapy Reduces the Severity of Climacteric Symptoms among BRCA Mutation Carriers Who Have Surgical Menopause While Mindfulness-Based Stress Reduction May Evoke Adverse EffectsSemantic proximity Read

The Impact of Breast Cancer Risk Factors: Socio-Economic, Hormonal, and Clinical Insights from Hassan II Regional Oncology Center, MoroccoSemantic proximity Read